Cargando…
Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead
AIMS: To evaluate early outcomes of patients with hepatocellular carcinoma (HCC) treated with a novel radiopaque bead, the 75–150 μm DC Bead LUMI™ (Biocompatibles UK Ltd). MATERIALS AND METHODS: This was a retrospective review of the first 40 consecutive patients at a UK tertiary hepato-biliary cent...
Autores principales: | Reicher, John, Mafeld, Sebastian, Priona, Georgia, Reeves, Helen L., Manas, Derek M., Jackson, Ralph, Littler, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775038/ https://www.ncbi.nlm.nih.gov/pubmed/31455987 http://dx.doi.org/10.1007/s00270-019-02317-3 |
Ejemplares similares
-
Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
por: Reeves, Helen L, et al.
Publicado: (2022) -
Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy
por: Beaton, Laura, et al.
Publicado: (2022) -
Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection
por: Mafeld, Sebastian, et al.
Publicado: (2018) -
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes
por: Mafeld, Sebastian, et al.
Publicado: (2019) -
Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes
por: Mafeld, Sebastian, et al.
Publicado: (2018)